By Sneha S K April 2 (Reuters) - Immunovant said on Thursday that its therapy failed to reduce eye bulging when tested in ...

Immunovant’s first-generation FcRn inhibitor flunked a pair of phase 3 eye disease trials, appearing to end the last hopes of ...

Exclusive licensing of new breakthrough, clinic-grade tests to the RemoniHealth platform, solidifies its position as the only ...

Despite hitting its primary endpoint, Viridian’s thyroid eye disease antibody failed to ease eye bulging to the degree that ...

The Roivant group company said that treatment with batoclimab had shown some improvement in the eye bulging (proptosis) ...

Researchers have predicted that cases of glaucoma, a common eye condition that can lead to blindness if not treated, are expected to increase around the world in the coming years. There is a ...

A pharmaceutical company has issued a voluntary recall of over 3 million of its over-the-counter eye-drop products after the ...

Thyroid eye disease is a chronic autoimmune disorder that inflames tissues behind the eye. Swelling can cause dry, irritated eyes, bulging, light sensitivity, and double vision. Thyroid eye disease ...

Nearly a quarter of patients with hidradenitis suppurativa (HS) experienced concomitant eye disease, and among those who did, nearly one third had a partial response with treatment, results from a ...

April 2 (Reuters) - Immunovant said on Thursday that its therapy to treat a type of eye disease failed to meet the main goals in two late-stage studies. Shares of the company were down 12% in ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony, in a project by clinical researchers at UCL and Moorfields Eye ...